Jen Robinson | Vice President, Investor Relations |
Steve Hoerter | President and Chief Executive Officer |
Dan Martin | Chief Commercial Officer |
Matt Sherman | Chief Medical Officer |
Tucker Kelly | Chief Financial Officer |
Daniel Wolle | JPMorgan |
Chris Raymond | Piper Sandler |
Eun Yang | Jefferies |
Charles Zhu | Guggenheim Securities |
Srikripa Devarakonda | Truist Securities |
Reni Benjamin | JMP Securities |
Peter Lawson | Barclays |
Arlinda Lee | Canaccord |
Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Jen Robinson, Vice President of Investor Relations, Jen?
Thank you operator. Welcome, and thank you for joining us today to discuss Deciphera second quarter 2021 financial results.